
The Healthier Choice Recovery lists 3 outpatient addiction levels: UAE payer checks
A Los Angeles outpatient addiction model shows what UAE clinics, insurers and patients should verify before treatment.
How Zavis verifies this coverage
Editorial standards, source rules, methodology, and review provenance are public.
The Healthier Choice Recovery said in a Press Advantage release carried by FinancialContent on 9 September 2026 that it provides outpatient addiction treatment across Los Angeles, a model UAE operators should read as a payer-access and licensing story rather than a foreign clinic announcement.
The highest-stakes readers are clinic owners, COOs and insurers. Dubai clinics need to know whether addiction care can be delivered under their Dubai Health Authority (DHA) facility licence, which clinician categories can treat substance-use disorders, and which services need referral, prior authorisation or exclusion checks. Abu Dhabi providers face the same questions under the Department of Health Abu Dhabi (DOH). Providers in Sharjah, Ajman, Ras Al Khaimah, Fujairah and Umm Al Quwain should check Ministry of Health and Prevention (MOHAP) licensing and facility scope before marketing any addiction programme.
What the Los Angeles provider is selling
The Healthier Choice Recovery, based at 15335 Morrison Street in Sherman Oaks, presents itself as an outpatient addiction and mental health provider. Its website lists three outpatient care levels: partial hospitalisation programme, intensive outpatient programme and outpatient programme. It also lists dual-diagnosis treatment, aftercare support, individual therapy, group therapy, cognitive behavioural therapy, dialectical behaviour therapy, motivational interviewing and EMDR therapy.
The provider says it accepts most insurance providers but states on its insurance form that Medicaid and Medicare are not accepted. The Joint Commission’s public directory lists The Healthier Choice Recovery LLC at the same Sherman Oaks address and includes intensive outpatient services, high-intensity outpatient services and outpatient therapy in its accredited behavioural health scope.
For UAE operators, the commercial signal is the packaging. Addiction care is being sold as a step-down and work-compatible service, rather than a residential stay. That matters in Dubai, where many patients are expatriate employees with employer-funded cover and limited tolerance for long absence from work.
UAE clinics should test licence, tariff and pathway first
The UAE is a different regulatory market. Addiction treatment touches psychiatry, controlled medicines, confidentiality, employer absence, family consent and possible criminal exposure. The federal framework changed when Federal Law No. 10 of 2023 on Psychiatric Health came into force on 30 May 2024, replacing the 1981 law, according to legal briefings on the new mental health law and the UAE legislation portal.
Before copying a Los Angeles-style outpatient addiction pathway, a UAE clinic should document four items:
- Facility scope: whether DHA, DOH or MOHAP licensing allows addiction medicine, psychiatry, psychology, group therapy and telehealth.
- Clinician scope: whether the named psychiatrist, psychologist, counsellor or nurse is licensed for the service being billed.
- Payer pathway: whether Daman, Sukoon or another insurer requires prior authorisation, referral, diagnosis coding or a network facility.
- Risk protocol: how the clinic handles intoxication, withdrawal, self-harm risk, safeguarding and escalation to inpatient care.
Prices should be handled carefully. Public UAE price lists for addiction-specific outpatient programmes are patchy. Operators should benchmark by requesting written cash rates and insurer tariffs for psychiatry consultation, psychotherapy, group therapy, drug testing and programme-day codes. Patients should ask for a written estimate before intake, including assessment fees, weekly session frequency, laboratory tests and medication costs.
What insurers and patients should ask next
For CFOs and revenue-cycle teams, the first issue is benefit design. Sukoon publishes HealthPlus plan limits running from AED 150,000 to AED 5 million and lists mental health and wellbeing therapy cover on global health pages. Daman plan schedules vary by product and year; one published schedule lists psychiatric treatment cover up to AED 10,000 per person per year for a specific plan context. Those figures are plan-specific, so providers should verify the member’s policy in the insurer portal before admission.
For patients, eligibility is practical. A Dubai resident should first check whether the provider is DHA-licensed and in network. An Abu Dhabi or Al Ain patient should check DOH licensing and whether Daman or Thiqa rules require a named network provider, referral or pre-approval. Northern emirates patients should confirm MOHAP licensing and insurer network status before paying a deposit.
The Healthier Choice Recovery release shows how outpatient addiction care is being packaged in a mature private-pay and commercial-insurance market. UAE clinics can learn from the structure, but the local test is stricter: licensed scope, documented clinical governance and payer confirmation before marketing. Patients and employers looking for licensed mental health options in the UAE should start with the UAE Open Healthcare Directory for licensed mental health providers, then confirm coverage directly with the insurer and regulator registry.
Zavis Intelligence
Healthcare Industry Desk
Contributing to UAE healthcare industry coverage
Related coverage
FAQ
What is happening in UAE healthcare industry?
A Los Angeles outpatient addiction model shows what UAE clinics, insurers and patients should verify before treatment.



